Related Experiment Video
Updated: Jan 13, 2026

04:41
Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
3.3K
Current and Emerging Strategies in the Management of Keloid Scars: A Comprehensive Review
Lamorna Coyle1, Gabrielle Odoom1, Joseph A Ricci1
1Division of Plastic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
The American Surgeon
|October 29, 2025
Summary
Keloid scars are a pathological healing issue. This review summarizes current and novel treatments for keloids, addressing their effectiveness and limitations.
Area of Science:
- Dermatology
- Wound Healing
- Immunology
Background:
- Keloids are pathological scars with distinct characteristics like invasion beyond borders, pain, and high recurrence.
- Current treatments target aberrant immune responses but often yield inadequate clinical responses.
- Management challenges persist due to patient-specific factors, scar location, and etiology.
Purpose of the Study:
- To provide a comprehensive review of keloid and hypertrophic scar treatment strategies.
- To summarize the shortcomings of existing therapeutic options.
- To offer recommendations on dosage and duration for available treatments.
Main Methods:
- Literature review of current and novel therapeutic strategies for keloids and hypertrophic scars.
- Analysis of conservative management options (e.g., pressure therapy, silicone, topical agents, steroid injections).
- Evaluation of invasive approaches (e.g., surgical excision, radiation therapy, chemotherapeutic agents) and novel therapies (e.g., calcium-channel blockers, mesenchymal stem cells).
Main Results:
- Conservative and invasive treatments show variable efficacy, often dependent on individual patient factors.
- High recurrence rates persist despite multimodal treatment approaches.
- Novel therapies show promise but require further investigation for optimal application.
Conclusions:
- Keloid management remains challenging, necessitating a review of current and emerging treatment modalities.
- A combination of therapies is often required, but recurrence is common.
- Further research is crucial to optimize novel treatments like calcium-channel blockers and mesenchymal stem cells for keloid management.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
Inflammatory Bowel Disease V: Surgical Management
438
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
438
Burn Injuries
4.1K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.1K
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K

